Role of liver sinusoidal endothelial cells in liver diseases

J Gracia-Sancho, E Caparrós… - Nature reviews …, 2021‏ - nature.com
Liver sinusoidal endothelial cells (LSECs) form the wall of the hepatic sinusoids. Unlike
other capillaries, they lack an organized basement membrane and have cytoplasm that is …

Mechanical communication in fibrosis progression

Y Long, Y Niu, K Liang, Y Du - Trends in cell biology, 2022‏ - cell.com
Mechanical hallmarks of fibrotic microenvironments are both outcomes and causes of
fibrosis progression. Understanding how cells sense and transmit mechanical cues in the …

Kupffer cell–like syncytia replenish resident macrophage function in the fibrotic liver

M Peiseler, B Araujo David, J Zindel, BGJ Surewaard… - Science, 2023‏ - science.org
Kupffer cells (KCs) are localized in liver sinusoids but extend pseudopods to parenchymal
cells to maintain their identity and serve as the body's central bacterial filter. Liver cirrhosis …

Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease

A Hammoutene, PE Rautou - Journal of hepatology, 2019‏ - Elsevier
Non-alcoholic fatty liver disease (NAFLD) and its complications are an expanding health
problem associated with the metabolic syndrome. Liver sinusoidal endothelial cells (LSECs) …

Pathophysiology of decompensated cirrhosis: portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction

C Engelmann, J Clària, G Szabo, J Bosch… - Journal of …, 2021‏ - Elsevier
Patients with acutely decompensated cirrhosis have a dismal prognosis and frequently
progress to acute-on-chronic liver failure, which is characterised by hepatic and extrahepatic …

Cell senescence in liver diseases: pathological mechanism and theranostic opportunity

D Sanfeliu-Redondo, A Gibert-Ramos… - Nature Reviews …, 2024‏ - nature.com
The liver is not oblivious to the passage of time, as ageing is a major risk factor for the
development of acute and chronic liver diseases. Ageing produces alterations in all hepatic …

[HTML][HTML] Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease

Z Boyer-Diaz, P Aristu-Zabalza, M Andrés-Rozas… - Journal of …, 2021‏ - Elsevier
Background & aims In advanced chronic liver disease (ACLD), deregulated hepatic
necroinflammatory processes play a key role in the development of liver microvascular …

Sequential nano-penetrators of capillarized liver sinusoids and extracellular matrix barriers for liver fibrosis therapy

LF Zhang, XH Wang, CL Zhang, J Lee, BW Duan… - ACS …, 2022‏ - ACS Publications
During liver fibrogenesis, liver sinusoidal capillarization and extracellular matrix (ECM)
deposition construct dual pathological barriers to drug delivery. Upon capillarization, the …

[HTML][HTML] Nonalcoholic fatty liver disease and chronic kidney disease: epidemiology, pathogenesis, and clinical and research implications

A Lonardo, A Mantovani, G Targher, G Baffy - International Journal of …, 2022‏ - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic
liver disease worldwide, affecting up to~ 30% of adult populations. NAFLD defines a …

Role of extracellular vesicles in liver diseases and their therapeutic potential

E Kostallari, S Valainathan, L Biquard, VH Shah… - Advanced drug delivery …, 2021‏ - Elsevier
More than eight hundred million people worldwide have chronic liver disease, with two
million deaths per year. Recurring liver injury results in fibrogenesis, progressing towards …